We are live on
!
Find out more
AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
29 hedge funds and large institutions have $5.32M invested in Agile Therapeutics in 2018 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
24% less funds holding
Funds holding: 38 → 29 (-9)
40% less capital invested
Capital invested by funds: $8.81M → $5.32M (-$3.49M)
60% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 15
Holders
29
Holders Change
-9
Holders Change %
-23.68%
% of All Funds
0.66%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
6
Increased
6
Reduced
6
Closed
15
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$1K
Top Buyers
| 1 |
FI
Fosun International
Hong Kong,
China
|
+$171K |
| 2 |
Renaissance Technologies
New York
|
+$158K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$26.4K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$23.4K |
| 5 |
VF
Virtu Financial
New York
|
+$23.4K |
